Skip to content

A study on dosage and administration of the hair growth formula.

A study on dosage and administration of the hair growth formula. - A study on dosage and administration of the hair growth formula.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020318
Enrollment
40
Registered
2015-12-24
Start date
2015-12-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia

Interventions

Apply the hair growth formula once a day for 6 months. Apply the hair growth formula twice a day for 6 months.

Sponsors

Inforward, inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) People with subjective symptoms of androgenic alopecia. 2) People who apply to class II vertex to class V by Hamilton-Norwood's classification.

Exclusion criteria

Exclusion criteria: 1) People with alopecia other than androgenic alopecia (alopecia areata, alopecia with thyroid disease, etc.), or with alopecia of unknown origin. 2) People who have sudden hair loss, or macular hair loss. 3) People who have a wide range of wound, rash or inflammation on scalp. 4) People who are using the hair growth formula, or used it within 1 month. 5) People who are using the external medicine on scalp, or used it within 1 month. 6) People who take anti-inflammation, anti-histamine or anti-hormonal medicines. 7) People with experiencing a side effects such as allergy by using the hair growth formula. 8) People with experiencing an allergy by using the medicines or cosmetics. 9) People with experiencing the hair transplant. 10) The length of parietal hair is shorter than 3cm. 11) People with many gray hair. 12) Oneself or the living family work at advertising agency, research or consultant agency, mass media, distribution industry, or industry of cosmetics, foods or toiletry items. 13) People who participate in other clinical trials. 14) People who judged as unsuitable for this study by a principal investigator or sub-investigators.

Design outcomes

Primary

MeasureTime frame
Hair thickness before and after 6 months application.

Secondary

MeasureTime frame
Hair density, anagen hair ratio, and an assessment by dermatologist before and after 6 months application.

Countries

Japan

Contacts

Public ContactKazunori Takashima

Inforward, inc. Ebisu Skin Research Center

takashima@inforward.co.jp03-5793-8712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026